Browse the corpus

REFERENCES Dellinger RP, Levy MM, Carlet JM, et al, “Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008,” Intensive Care Med , 2008, 34(1):17-60. Available at file://www.ncbi.nlm.nih.gov/pmc/articles/PMC2249616/pdf/134_2007_Article_934.pdf [PubMed 18058085 ] Dellinger RP, Levy MM, Rhodes A, et al, “Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012,” Crit Care Med , 2013, 41(2):580-637. [PubMed 23353941 ] Meretoja OA, Taivainen T, Jalkanen L, et al, “Synergism Between Atracurium and Vecuronium in Infants and Children During Nitrous Oxide-Oxygen-Alfentanil Anaesthesia,” Br J Anaesth , 1994, 73(5):605-7. [PubMed 7826787 ] Murray MJ, Cowen J, DeBlock H, et al, “Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient. Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists, American College of Chest Physicians,” Crit Care Med , 2002, 30(1):142-56. [PubMed 11902255 ] Peat SJ, Potter DR, and Hunter JM, “The Prolonged Use of Atracurium in a Patient With Tetanus,” Anaesthesia , 1988, 43(11):962-3. [PubMed 3213921 ] Yate PM, Flynn PJ, Arnold RW, et al, “Clinical Experience and Plasma Laudanosine Concentrations During the Infusion of Atracurium in the Intensive Therapy Unit,” Br J Anaesth , 1987, 59(2):211-7. [PubMed 3548792 ] Topic 8973 Version 36.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1104-122.72.76.133-E4AAF914B2-S244013.14]